Inspirna
$50M – Series D
Inspirna, a biotech startup focused on the development cancer treatment drugs using microRNA biology, has raised $50M in Series D funding led by Vivo Capital and Sand Capital Ventures. Founded by Masoud Tavazoie, Saeed Tavazoie, Shahram Seyedin-Noor, Sohail Tavazoie in 2010, Inspirna has now raised a total of $139.5M in reported equity funding.
Make an impact on your bottom line and drive leads!
The AlleyWatch audience is driving progress and innovation on a global scale. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including strategic brand placement, lead generation, and thought leadership in front of an audience that comprises the vast majority of key decision-makers in the NYC business community and beyond. Learn more about advertising to NYC Tech, at scale.
